215 related articles for article (PubMed ID: 35165352)
1. Systematic analysis of putative phage-phage interactions on minimum-sized phage cocktails.
Molina F; Menor-Flores M; Fernández L; Vega-Rodríguez MA; García P
Sci Rep; 2022 Feb; 12(1):2458. PubMed ID: 35165352
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014.
Villarroel J; Larsen MV; Kilstrup M; Nielsen M
Viruses; 2017 Nov; 9(11):. PubMed ID: 29099783
[TBL] [Abstract][Full Text] [Related]
3. A New Pipeline for Designing Phage Cocktails Based on Phage-Bacteria Infection Networks.
Molina F; Simancas A; Ramírez M; Tabla R; Roa I; Rebollo JE
Front Microbiol; 2021; 12():564532. PubMed ID: 33664712
[TBL] [Abstract][Full Text] [Related]
4. Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers.
McCallin S; Sarker SA; Sultana S; Oechslin F; Brüssow H
Environ Microbiol; 2018 Sep; 20(9):3278-3293. PubMed ID: 30051571
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Lytic Phage Cocktails on
Kifelew LG; Warner MS; Morales S; Thomas N; Gordon DL; Mitchell JG; Speck PG
Viruses; 2020 May; 12(5):. PubMed ID: 32443619
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Podoviridae and Myoviridae bacteriophages to the effectiveness of anti-staphylococcal therapeutic cocktails.
Kornienko M; Kuptsov N; Gorodnichev R; Bespiatykh D; Guliaev A; Letarova M; Kulikov E; Veselovsky V; Malakhova M; Letarov A; Ilina E; Shitikov E
Sci Rep; 2020 Oct; 10(1):18612. PubMed ID: 33122703
[TBL] [Abstract][Full Text] [Related]
7. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria.
Latz S; Wahida A; Arif A; Häfner H; Hoß M; Ritter K; Horz HP
J Basic Microbiol; 2016 Oct; 56(10):1117-1123. PubMed ID: 27194637
[TBL] [Abstract][Full Text] [Related]
8. Lytic Activity of Various Phage Cocktails on Multidrug-Resistant Bacteria.
Ozkan I; Akturk E; Yeshenkulov N; Atmaca S; Rahmanov N; Atabay HI
Clin Invest Med; 2016 Dec; 39(6):27504. PubMed ID: 27917795
[TBL] [Abstract][Full Text] [Related]
9. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
10. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
11. Phage and phage cocktails formulations.
Mani I
Prog Mol Biol Transl Sci; 2023; 200():159-169. PubMed ID: 37739554
[TBL] [Abstract][Full Text] [Related]
12. Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence.
Gao D; Ji H; Wang L; Li X; Hu D; Zhao J; Wang S; Tao P; Li X; Qian P
Microbiol Spectr; 2022 Oct; 10(5):e0291422. PubMed ID: 36165776
[TBL] [Abstract][Full Text] [Related]
13. Advancing phage therapy through the lens of virus host-breadth and emergence potential.
Bono LM; Mao S; Done RE; Okamoto KW; Chan BK; Turner PE
Adv Virus Res; 2021; 111():63-110. PubMed ID: 34663499
[TBL] [Abstract][Full Text] [Related]
14. Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.
Burrowes BH; Molineux IJ; Fralick JA
Viruses; 2019 Mar; 11(3):. PubMed ID: 30862096
[TBL] [Abstract][Full Text] [Related]
15. Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy.
Azam AH; Tanji Y
Appl Microbiol Biotechnol; 2019 Jun; 103(11):4279-4289. PubMed ID: 30997551
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
[TBL] [Abstract][Full Text] [Related]
17. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
[TBL] [Abstract][Full Text] [Related]
18. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection.
Terwilliger A; Clark J; Karris M; Hernandez-Santos H; Green S; Aslam S; Maresso A
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696479
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of two Staphylococcus aureus phage cocktails in cheese production.
El Haddad L; Roy JP; Khalil GE; St-Gelais D; Champagne CP; Labrie S; Moineau S
Int J Food Microbiol; 2016 Jan; 217():7-13. PubMed ID: 26476571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
